Finally, we have identified a natural product capable of inhibiting the nuclear translocation of TRAF4 from the plasma membrane, presenting a novel and promising therapeutic approach for the treatment of metastatic cancer. The gene discussed is TRAF4; the disease is metastatic malignant neoplasm.